NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 25 filers reported holding NEVRO CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,225,645 | +1.1% | 6,667,000 | 0.0% | 0.03% | -6.7% |
| Q2 2023 | $6,160,308 | -1.7% | 6,667,000 | 0.0% | 0.03% | -6.2% |
| Q1 2023 | $6,266,980 | +20.5% | 6,667,000 | +17.6% | 0.03% | -15.8% |
| Q4 2022 | $5,199,473 | -3.1% | 5,667,000 | 0.0% | 0.04% | +18.8% |
| Q3 2022 | $5,364,000 | +1.6% | 5,667,000 | 0.0% | 0.03% | +23.1% |
| Q2 2022 | $5,281,000 | -83.8% | 5,667,000 | -81.2% | 0.03% | -71.1% |
| Q1 2022 | $32,611,000 | -8.2% | 30,167,000 | -5.5% | 0.09% | +52.5% |
| Q4 2021 | $35,522,000 | -17.6% | 31,917,000 | 0.0% | 0.06% | -30.6% |
| Q3 2021 | $43,108,000 | +13.5% | 31,917,000 | +45.6% | 0.08% | -1.2% |
| Q2 2021 | $37,971,000 | +149.9% | 21,917,000 | +119.2% | 0.09% | +91.1% |
| Q1 2021 | $15,196,000 | – | 10,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 109,251,000 | $102,018,584 | 3.22% |
| Opti Capital Management, LP | 19,500,000 | $18,574 | 1.34% |
| Context Capital Management, LLC | 10,702 | $10,207 | 0.82% |
| PFM Health Sciences, LP | 17,500,000 | $16,341,500 | 0.77% |
| LINDEN ADVISORS LP | 21,366,000 | $19,993,448 | 0.20% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,595,000 | $1,543,041 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,667,000 | $6,225,645 | 0.03% |
| Rock Springs Capital Management LP | 500,000 | $472,128 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 0 | $933 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |